MinION Essentials: Everything you need to know about the world’s most cost-effective and accessible sequencer
)
Whether you’re curious about MinION, have a device that you don’t use, or want to maximise your current experiments, this webinar will provide practical guidance, tips and real-world advice.
Plus, our experts will answer your MinION queries during the session.
PLEASE NOTE: This webinar will be offered in two timezones. Please select your preferred option on the form below.
You will learn:
About the MinION device, its core capabilities, and how real‑time nanopore sequencing can be applied across diverse research settings
How library preparation, flow cell handling, and analysis with EPI2ME fit together to create a streamlined, accessible sequencing pipeline, with practical examples
Practical tips and advice, from compute considerations to navigating Nanopore data formats. Our experts will also provide guidance on any MinION questions raised.
Meet the speakers
)
Anna Maria Niewiadomska, Associate Director, Segment Marketing — Micro & Infectious Disease, Oxford Nanopore TechnologiesAnna Maria Niewiadomska is Associate Director, Segment Marketing — Micro & Infectious Disease. In her role, Anna drives the development of new markets in the infectious disease and public health space. She received her PhD in molecular microbiology and immunology from the Johns Hopkins School of Public Health. Prior to joining Oxford Nanopore, Anna worked on multiple projects focusing on host-virus interactions, mathematical modelling of antimicrobial resistance, microbial bioinformatics, and emerging infectious disease outbreaks. She combines a deep knowledge of experimental and in silico methods for generation and analysis of microbial genomic data.
)
Wyatt Prewit, Technical Applications Specialist, Oxford Nanopore TechnologiesWyatt is a Texas native and earned his BS in Microbiology and MS in Molecular Pathology from Texas Tech University. After moving to Houston in 2020, he joined MD Anderson Cancer Center where he supported the validation and implementation of NGS assays for solid tumours. Wyatt later worked with Houston-area biotechnology start-ups before joining Oxford Nanopore as a Technical Applications Scientist helping users optimise workflows and troubleshoot challenges to maximise their sequencing data.
)
Scott Markland, Product Marketing Manager — MinION and GridION, Oxford Nanopore TechnologiesScott Markland is a product marketing and commercial strategy professional with over 14 years of experience in biotechnology, molecular diagnostics, and genomics. He has a proven track record of bringing innovative technologies to market, leading global product launches, product strategy, and customer engagement. Having progressed from laboratory R&D to a variety of commercial roles, Scott combines deep scientific expertise with strategic marketing to accelerate the adoption of transformative technologies and improve outcomes for scientists across a wide variety of disciplines.
)
Angela Von, Technical Services Manager ANZ, Oxford Nanopore TechnologiesWith over 12 years of experience in molecular biology, Angela leads a team dedicated to supporting customers across research and clinical settings at Oxford Nanopore Technologies. She works closely with laboratories to provide personalised workflow consultation, technical guidance, and in-house training, helping customers successfully implement nanopore sequencing technologies and achieve their experimental and clinical goals.
